I

Immunocore Tech Stack

T cell receptor biotechnology company developing immunotherapies for cancer and infectious diseases

Biotechnology Research Abingdon, England 201–500 employees Founded 2008 Privately Held

Immunocore is a TCR-focused biotech company running clinical programs across oncology, infectious disease, and autoimmune indications. The tech stack reveals a heavily regulated, data-intensive operation: clinical trial management (Medidata Rave, Oracle Clinical), statistical analysis (SAS, R, dplyr), and regulatory compliance tooling (Veeva, CDISC) dominate. The hiring mix—skewed toward director-level roles and substantial clinical/regulatory functions—reflects a company scaling toward late-stage development and commercial launch, with cutaneous melanoma as an active launch project.

Tech Stack 21 technologies

Core StackSAS NetSuite Medidata Rave Oracle Clinical CDISC Microsoft Office Agiloft Veeva PromoMats Excel Word PowerPoint HTML SharePoint Veeva SDS-PAGE HPLC Phoenix R dplyr

What Immunocore Is Building

◆Challenges

Enhancing inspection readiness
Ensuring patient access to therapies
Reducing turnover
High turnover
Meeting sales goals
Improving clinical compliance
Ensuring product access
Improving tmf process efficiency
Workflow improvement
Compliance with gcp and gvp

▲Active Projects

Incentive compensation plan design
Design sales performance reports
Local market analysis and business planning
Congress symposiums
Local promotional speaker programs
Early access programs
Design reports and tools to monitor attainment of goals
Tmf support model evolution
Cutaneous melanoma launch
Us medical plan for presence, coverage, and kol engagement at key national and regional congresses and meetings

Hiring Activity

Steady60 roles · 20 in 30d

Department

Sales

13

Research

9

Healthcare

8

Ops

5

Regulatory

5

Manufacturing

3

Marketing

3

Clinical

2

Seniority

Director

24

Senior

16

Mid

10

Manager

7

Principal

1

Notable leadership hires: Finance Director, Indication Marketing Lead, Clinical Supply Lead

Company intelligence

Find more companies like Immunocore by tech stack, pain points and active projects

Get started free

About Immunocore

Immunocore develops first-in-class T cell receptor (TCR) therapies targeting oncology, infectious disease, and autoimmune conditions. Based in Abingdon, England, the company operates across 201–500 employees with active hiring in the United States, United Kingdom, Australia, and India. Operations span research, clinical development, manufacturing, regulatory affairs, and commercial functions. Current priorities include clinical program advancement, commercial readiness (sales performance infrastructure, market analysis, key opinion leader engagement), and operational efficiency—particularly in regulatory compliance, trial management, and patient access workflows.

HeadquartersAbingdon, England

Company Size201–500 employees

Founded2008

Hiring MarketsUnited States, United Kingdom, Australia, India

Frequently Asked Questions

What is Immunocore's technology platform?

Immunocore develops T cell receptor (TCR) therapies—a class of biological immunotherapies designed to redirect T cells against cancer and infectious disease targets. The platform addresses unmet needs in oncology, infectious disease, and autoimmune disorders.

What is Immunocore's current pipeline focus?

Active programs include cutaneous melanoma development and launch preparation. Projects reflect late-stage readiness: sales performance design, clinical trial monitoring infrastructure, key opinion leader engagement strategy, and regulatory compliance (GCP/GVP alignment, TMF process optimization).